Search Results - "Tilanus, M."

Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease by WIGGELINKHUIZEN, M., TILANUS, M. E. C., BOLLEN, C. W., HOUWEN, R. H. J.

“…Summary Background  No consensus is available on the optimal initial treatment in Wilson disease. Aim  To assess systematically the available literature of…”
Get full text

New insights in HLA‐E polymorphism by refined analysis of the full‐length gene by Olieslagers, T. I., Voorter, C. E. M., Groeneweg, M., Xu, Y., Wieten, L., Tilanus, M. G. J.

“…Background Human leukocyte antigen (HLA)‐E is a non‐classical HLA class I molecule that plays a role in both the innate and the adaptive immune response…”
Get full text

Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis by Heemskerk-Gerritsen, B.A.M., Menke-Pluijmers, M.B.E., Jager, A., Tilanus-Linthorst, M.M.A., Koppert, L.B., Obdeijn, I.M.A., van Deurzen, C.H.M., Collée, J.M., Seynaeve, C., Hooning, M.J.

“…To prospectively assess the efficacy of bilateral risk-reducing mastectomy (BRRM) when compared with surveillance on breast cancer (BC) risk and mortality in…”
Get full text

Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis by Phi, Xuan-Anh, Saadatmand, Sepideh, De Bock, Geertruida H, Warner, Ellen, Sardanelli, Francesco, Leach, Martin O, Riedl, Christopher C, Trop, Isabelle, Hooning, Maartje J, Mandel, Rodica, Santoro, Filippo, Kwan-Lim, Gek, Helbich, Thomas H, Tilanus-Linthorst, Madeleine MA, van den Heuvel, Edwin R, Houssami, Nehmat

“…Background: We investigated the additional contribution of mammography to screening accuracy in BRCA1/2 mutation carriers screened with MRI at different ages…”
Get full text

The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosis by Tilanus, T B M, Groothuis, J T, TenBroek-Pastoor, J M C, Feuth, T B, Heijdra, Y F, Slenders, J P L, Doorduin, J, Van Engelen, B G, Kampelmacher, M J, Raaphorst, J

“…Non-invasive ventilation (NIV) improves survival and quality of life in amyotrophic lateral sclerosis (ALS) patients. The timing of referral to a home…”
Get full text

Differential effects of donor‐specific HLA antibodies in living versus deceased donor transplant by Kamburova, E. G., Wisse, B. W., Joosten, I., Allebes, W. A., Meer, A., Hilbrands, L. B., Baas, M. C., Spierings, E., Hack, C. E., Reekum, F. E., Zuilen, A. D., Verhaar, M. C., Bots, M. L., Drop, A. C. A. D., Plaisier, L., Seelen, M. A. J., Sanders, J. S .F., Hepkema, B. G., Lambeck, A. J. A., Bungener, L. B., Roozendaal, C., Tilanus, M. G. J., Voorter, C. E., Wieten, L., Duijnhoven, E. M., Gelens, M., Christiaans, M. H. L., Ittersum, F. J., Nurmohamed, S. A., Lardy, N. M., Swelsen, W., Pant, K. A., Weerd, N. C., Berge, I. J. M., Bemelman, F. J., Hoitsma, A., Boog, P. J. M., Fijter, J. W., Betjes, M. G. H., Heidt, S., Roelen, D. L., Claas, F. H., Otten, H. G.

“…The presence of donor‐specific anti‐HLA antibodies (DSAs) is associated with increased risk of graft failure after kidney transplant. We hypothesized that DSAs…”
Get full text

Follicular T helper cells and humoral reactivity in kidney transplant patients by de Graav, G. N., Dieterich, M., Hesselink, D. A., Boer, K., Clahsen‐van Groningen, M. C., Kraaijeveld, R., Litjens, N. H. R., Bouamar, R., Vanderlocht, J., Tilanus, M., Houba, I., Boonstra, A., Roelen, D. L., Claas, F. H. J., Betjes, M. G. H., Weimar, W., Baan, C. C.

“…Summary Memory B cells play a pivotal role in alloreactivity in kidney transplantation. Follicular T helper (Tfh) cells play an important role in the…”
Get full text

The role of gene polymorphism in HLA class I splicing by Voorter, C. E. M., Gerritsen, K. E. H., Groeneweg, M., Wieten, L., Tilanus, M. G. J.

“…Summary Among the large number of human leucocyte antigen (HLA) alleles, only a few have been identified with a nucleotide polymorphism impairing correct…”
Get full text

Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia by HUISMAN, C, DE WEGER, R. A, DE VRIES, L, TILANUS, M. G. J, VERDONCK, L. F

“…The role of chimerism analysis as a prognostic indicator of relapse after hematopoietic stem cell transplantation (SCT) is controversial. We monitored…”
Get full text

Saddlebags: A software interface for submitting full‐length HLA allele sequences to the EMBL‐ENA nucleotide database by Matern, B. M., Groeneweg, M., Voorter, C. E. M., Tilanus, M. G. J.

“…Submission of full‐length HLA allele sequences presents a unique challenge, both for high‐throughput sequencing laboratories and smaller diagnostic…”
Get full text

A new HLA‐C05 allele, HLA‐C05:156, characterized by full‐length hemizygous sequencing by Montanic, S., Voorter, C. E. M., Tilanus, M. G. J., Vidan‐Jeras, B.

“…HLA‐C*05:156 allele differs from C*05:01:01:02 by a nucleotide change in exon 2 at codon 9…”
Get full text

The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation by Lion, T, Watzinger, F, Preuner, S, Kreyenberg, H, Tilanus, M, de Weger, R, van Loon, J, de Vries, L, Cavé, H, Acquaviva, C, Lawler, M, Crampe, M, Serra, A, Saglio, B, Colnaghi, F, Biondi, A, van Dongen, J J M, van der Burg, M, Gonzalez, M, Alcoceba, M, Barbany, G, Hermanson, M, Roosnek, E, Steward, C, Harvey, J, Frommlet, F, Bader, P

“…Hematopoietic stem cell transplantation is becoming an increasingly important approach to treatment of different malignant and non-malignant disorders. There…”
Get full text

Polymorphism at residue 156 of the new HLA‐A02:683 allele suggests immunological relevance by Duygu, B., Matern, B. M., Groeneweg, M., Voorter, C. E. M., Tilanus, M. G. J.

“…HLA‐A*02:683 is most similar to 4 different HLA‐A*02 subtypes with a single nucleotide difference…”
Get full text

Breast cancer–related deaths according to grade in ductal carcinoma in situ: A Dutch population–based study on patients diagnosed between 1999 and 2012 by van Maaren, M.C., Lagendijk, M., Tilanus-Linthorst, M.M.A., de Munck, L., Pijnappel, R.M., Schmidt, M.K., Wesseling, J., Koppert, L.B., Siesling, S.

“…The incidence of ductal carcinoma in situ (DCIS) has drastically increased over the past decades. Because DCIS is resected after diagnosis similar to invasive…”
Get full text

How can we reduce costs of solid-phase multiplex-bead assays used to determine anti-HLA antibodies? by Kamburova, E. G., Wisse, B. W., Joosten, I., Allebes, W. A., van der Meer, A., Hilbrands, L. B., Baas, M. C., Spierings, E., Hack, C. E., van Reekum, F. E., van Zuilen, A. D., Verhaar, M., Bots, M. L., Drop, A. C. A. D., Plaisier, L., Seelen, M. A. J., Sanders, J. S. F., Hepkema, B. G., Lambeck, A. J., Bungener, L. B., Roozendaal, C., Tilanus, M. G. J., Vanderlocht, J., Voorter, C. E., Wieten, L., van Duijnhoven, E. M., Gelens, M., Christiaans, M. H. L., van Ittersum, F. J., Nurmohamed, A., Lardy, N. M., Swelsen, W., van der Pant, K. A., van der Weerd, N. C., ten Berge, I. J. M., Bemelman, F. J., Hoitsma, A., van der Boog, P. J. M., de Fijter, J. W., Betjes, M. G. H., Heidt, S., Roelen, D. L., Claas, F. H., Otten, H. G.

“…Solid‐phase multiplex‐bead assays are widely used in transplantation to detect anti‐human leukocyte antigen (HLA) antibodies. These assays enable high…”
Get full text

Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases by Brekelmans, C.T.M, Tilanus-Linthorst, M.M.A, Seynaeve, C, vd Ouweland, A, Menke-Pluymers, M.B.E, Bartels, C.C.M, Kriege, M, van Geel, A.N, Burger, C.W, Eggermont, A.M.M, Meijers-Heijboer, H, Klijn, J.G.M

“…Abstract Aim of the study Results on tumour characteristics and survival of hereditary breast cancer (BC), especially on BRCA2-associated BC, are inconclusive…”
Get full text

Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic by Heemskerk-Gerritsen, Bernadette A M, Brekelmans, Cecile T M, Menke-Pluymers, Marian B E, van Geel, Albert N, Tilanus-Linthorst, Madeleine M A, Bartels, Carina C M, Tan, Murly, Meijers-Heijboer, Hanne E J, Klijn, Jan G M, Seynaeve, Caroline

“…BRCA1/2 mutation carriers and women from a hereditary breast(/ovarian) cancer family have a highly increased risk of developing breast cancer (BC)…”
Get full text

Survival and prognostic factors in BRCA1-associated breast cancer by Brekelmans, C. T. M., Seynaeve, C., Menke-Pluymers, M., Brüggenwirth, H. T., Tilanus-Linthorst, M. M. A., Bartels, C. C. M., Kriege, M., van Geel, A. N., Crepin, C. M. G., Blom, J. C., Meijers-Heijboer, H., Klijn, J. G. M.

“…Background: Studies comparing survival in BRCA1-associated and sporadic breast cancer (BC) report inconsistent results and frequently concern small sample…”
Get full text

Proteomic characterization of microdissected breast tissue environment provides a protein‐level overview of malignant transformation by Braakman, René B. H., Stingl, Christoph, Tilanus‐Linthorst, Madeleine M. A., van Deurzen, Carolien H. M., Timmermans, Mieke A. M., Smid, Marcel, Foekens, John A., Luider, Theo M., Martens, John W. M., Umar, Arzu

“…Both healthy and cancerous breast tissue is heterogeneous, which is a bottleneck for proteomics‐based biomarker analysis, as it obscures the cellular origin of…”
Get full text

Short tandem repeat markers in diagnostics: what's in a repeat? by Tilanus, M G J

Get full text